Display options
Cite
Deng Y, Li AM, Zhao XM, et al. Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis. Oncol Lett. 2016;13(3):1228-1234doi: 10.3892/ol.2016.5537.
Deng, Y., Li, A. M., Zhao, X. M., Song, Z. J., & Liu, S. D. (2017). Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis. Oncology letters, 13(3), 1228-1234. https://doi.org/10.3892/ol.2016.5537
Deng, Yan, et al. "Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis." Oncology letters vol. 13,3 (2017): 1228-1234. doi: https://doi.org/10.3892/ol.2016.5537
Deng Y, Li AM, Zhao XM, Song ZJ, Liu SD. Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis. Oncol Lett. 2017 Mar;13(3):1228-1234. doi: 10.3892/ol.2016.5537. Epub 2016 Dec 27. PMID: 28454239; PMCID: PMC5403351.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Mar;13(3):1228-1234. doi: 10.3892/ol.2016.5537. Epub 2016 Dec 27.

Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis.

Oncology letters

Yan Deng, Ai-Min Li, Xin-Mei Zhao, Zhang-Juan Song, Si-De Liu

Affiliations

  1. Department of Gastroenterology, Southern Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
  2. Department of Gastroenterology, Haicang Hospital, Xiamen, Fujian 361000, P.R. China.

PMID: 28454239 PMCID: PMC5403351 DOI: 10.3892/ol.2016.5537

Abstract

The expression of tumor protein 53-inducible nuclear protein 1 (TP53INP1) is upregulated in certain cancers and downregulated in others. However, its expression in hepatocellular carcinoma (HCC) is not clear. The present study aimed to investigate the expression and prognostic value of TP53INP1 and its association with clinicopathological parameters in HCC. TP53INP1 expression in HCC tissue samples was examined via immunohistochemistry, western blotting and reverse transcription-quantitative polymerase chain reaction. Expression was categorized as high or low. The correlations of TP53INP1 expression with clinical characteristics and patients' prognoses were determined. TP53INP1 was frequently decreased in HCC tissues compared with adjacent non-tumorous liver tissues. This decreased expression was significantly associated with American Joint Committee on Cancer stage (P=0.014) and vascular invasion (P=0.024). Kaplan-Meier analysis further revealed that recurrence-free survival (RFS) (P=0.001) and overall survival (OS) (P=0.002) were significantly worse among patients with low TP53INP1 expression than among those with high TP53INP1 expression. In addition, multivariate analyses revealed that TP53INP1 was an independent predictor of OS [hazard ratio (HR)=2.680, 95% confidence interval (CI)=1.087-6.608, P=0.032) and RFS (HR=2.284, 95% CI=1.157-4.511, P=0.017). In conclusion, the expression of TP53INP1 was decreased in HCC, and TP53INP1 downregulation was an independent predictor of poor prognosis in patients with HCC.

Keywords: hepatocellular carcinoma; prognosis; tumor protein 53-induced nuclear protein 1

References

  1. Cancer. 1954 May;7(3):462-503 - PubMed
  2. Mol Cell Biol. 2007 Mar;27(6):2215-28 - PubMed
  3. Oncotarget. 2014 Nov 15;5(21):10678-91 - PubMed
  4. Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16170-5 - PubMed
  5. Oncogene. 2011 Jul 7;30(27):3049-61 - PubMed
  6. Prostate. 2012 Feb 1;72(2):117-28 - PubMed
  7. Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8 - PubMed
  8. Biochem Biophys Res Commun. 2011 Feb 11;405(2):278-84 - PubMed
  9. J Clin Pathol. 2013 Mar;66(3):169-77 - PubMed
  10. J BUON. 2016 Jul-Aug;21(4):917-924 - PubMed
  11. Anticancer Res. 2006 Nov-Dec;26(6B):4391-5 - PubMed
  12. Immunogenetics. 1999 Dec;50(5-6):255-70 - PubMed
  13. Mol Cell. 2001 Jul;8(1):85-94 - PubMed
  14. World J Surg. 2010 Apr;34(4):830-5 - PubMed
  15. Genes Chromosomes Cancer. 2009 Jan;48(1):10-21 - PubMed
  16. Prostate. 2012 Sep 1;72(12):1286-94 - PubMed
  17. J Biol Chem. 2003 Sep 26;278(39):37722-9 - PubMed
  18. Eur J Cell Biol. 2002 May;81(5):294-301 - PubMed
  19. Ann Surg Oncol. 2010 Jun;17(6):1471-4 - PubMed
  20. Int J Cancer. 2010 Dec 15;127(12):2893-917 - PubMed
  21. Cytogenet Genome Res. 2005;108(4):362 - PubMed
  22. World J Gastroenterol. 2006 Feb 7;12(5):691-6 - PubMed
  23. Cell Death Differ. 2012 Sep;19(9):1525-35 - PubMed
  24. J Biol Chem. 2001 Nov 23;276(47):44185-92 - PubMed
  25. Pathology. 2006 Dec;38(6):545-7 - PubMed
  26. J Hepatol. 2012 Apr;56(4):908-43 - PubMed

Publication Types